Shijun Zhang

Also affiliated with Guangxi Medical University, Tianjin Institute of Pharmaceutical Research (China), The First Affiliated Hospital, Sun Yat-sen University

Pharmacology, Toxicology and PharmaceuticsMedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 1 paper. Top paper: “Utilizing Drug Combo to improve the design of phase 1 trials for anticancer drugs.”.

Utilizing Drug Combo to improve the design of phase 1 trials for anticancer drugs.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.1571

N/A

0DataRank · unranked

0 citations

Shijun Zhang, Lai Wei, Dwight H. Owen, Lang Li, Lei Wang